Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul K. Paik
A Phase I Study of Obatoclax Mesylate, a BCL-2 Antagonist, Plus Topotecan in Solid Tumor Malignancies
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Relevance of Genetic Alterations in Squamous and Small Cell Lung Cancer
Annals of Translational Medicine
Medicine
Related publications
Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients With Advanced Solid Tumors or Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase I Study of Weekly Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
A Phase I and Pharmacokinetic Study of Intraperitoneal Topotecan
British Journal of Cancer
Cancer Research
Oncology
A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies
Cancer
Cancer Research
Oncology
Phase I Study of a Novel Taxane BMS-188797 in Adult Patients With Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Study of Paclitaxel, Topotecan, Cisplatin and Filgrastim in Patients With Newly Diagnosed Advanced Ovarian Epithelial Malignancies: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
